Our preliminary results suggest that erosion of TL and the changes of mtDNA-CN might be related to inflammation particularly associated with IL-17A plasma levels, and dopamine agonists/precursors treatment might modulate TL and mtDNA-CN in PD patients. Here, IL17A is linked to Parkinson disease.